Anxiolytic (5-HT1A partial agonist), non-benzodiazepine

Buspar (buspirone) Withdrawal

Buspar (buspirone) has a very mild discontinuation profile and does not produce a meaningful withdrawal syndrome. This is one of the reasons buspirone is preferred over benzodiazepines for chronic anxiety in patients without acute panic.

By Dr. Ben Soffer, DO — board-certified physician, at-home ketamine therapy in Florida and New Jersey.

Half-life

~2-3 hours.

Withdrawal timeline

OnsetFew days

Most patients notice no immediate effect of stopping buspirone.

PeakWeek 1

When symptoms do occur, they are typically mild and relate to return of underlying anxiety rather than a withdrawal syndrome.

Resolution1-2 weeks

Most patients return to baseline quickly.

Common symptoms

  • Return of anxiety
  • Mild irritability
  • Sleep changes

Less common

  • Headache

Tapering guidance

  • Buspirone can usually be tapered relatively quickly (e.g., halving the dose for 1 week, then stopping) without significant difficulty.
  • Coordinate with the prescribing physician.

Where ketamine therapy fits

Buspirone is fully compatible with at-home ketamine therapy. The two work through different mechanisms with no required washout. Continue buspirone as prescribed during ketamine treatment unless the prescribing physician advises otherwise.

Frequently asked questions

Does Buspar have a withdrawal syndrome?

No meaningful withdrawal syndrome. This is one of the main reasons buspirone is often preferred over benzodiazepines for chronic anxiety management.

Is Buspar compatible with ketamine therapy?

Yes. The two work through different mechanisms with no required washout.

Important: This page is informational and does not constitute medical advice or a recommendation to start, stop, or change any medication. Tapering psychiatric medications should always be coordinated with the prescribing physician. Compounded ketamine for anxiety, depression, PTSD, and chronic pain is not FDA approved.

Browse all medication withdrawal guides.